{"log_id": 5220699611964109335, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 0.000151, "average": 0.993994, "min": 0.947539}, "location": {"width": 147, "top": 68, "height": 14, "left": 58}, "words": "核准日期:2016年04月01日"}, {"probability": {"variance": 0.02877, "average": 0.901809, "min": 0.608026}, "location": {"width": 47, "top": 83, "height": 12, "left": 58}, "words": "修改日期"}, {"probability": {"variance": 3e-06, "average": 0.998854, "min": 0.994785}, "location": {"width": 405, "top": 102, "height": 44, "left": 144}, "words": "盐酸托烷司琼注射液说明书"}, {"probability": {"variance": 7.8e-05, "average": 0.994471, "min": 0.966541}, "location": {"width": 240, "top": 150, "height": 17, "left": 227}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 2.6e-05, "average": 0.996632, "min": 0.985396}, "location": {"width": 69, "top": 181, "height": 14, "left": 83}, "words": "【药品名称】"}, {"probability": {"variance": 0.00058, "average": 0.990007, "min": 0.90459}, "location": {"width": 177, "top": 197, "height": 14, "left": 80}, "words": "通用名称:盐酸托烷司琼注射液"}, {"probability": {"variance": 0.000301, "average": 0.983233, "min": 0.949116}, "location": {"width": 280, "top": 213, "height": 14, "left": 81}, "words": "英文名称: Tropi setron Hydrochloride Injection"}, {"probability": {"variance": 5e-06, "average": 0.997162, "min": 0.993775}, "location": {"width": 50, "top": 228, "height": 14, "left": 80}, "words": "汉语拼音"}, {"probability": {"variance": 0, "average": 0.748608, "min": 0.748608}, "location": {"width": 12, "top": 230, "height": 11, "left": 280}, "words": " Zh"}, {"probability": {"variance": 0.01381, "average": 0.936158, "min": 0.516766}, "location": {"width": 549, "top": 241, "height": 20, "left": 84}, "words": "【成份】本品主要成份为盐酸托烷司琼,化学名称为吲哚-3-甲酸1aH,5aH-托品-3a醇酯盐酸盐"}, {"probability": {"variance": 1e-06, "average": 0.998594, "min": 0.996705}, "location": {"width": 63, "top": 260, "height": 14, "left": 80}, "words": "化学结构式"}, {"probability": {"variance": 0.027361, "average": 0.913055, "min": 0.383585}, "location": {"width": 121, "top": 324, "height": 14, "left": 80}, "words": "分子式:C1-H2N2O2HC"}, {"probability": {"variance": 5.4e-05, "average": 0.993713, "min": 0.981062}, "location": {"width": 90, "top": 339, "height": 14, "left": 80}, "words": "分子量:320.81"}, {"probability": {"variance": 0.007529, "average": 0.973778, "min": 0.588269}, "location": {"width": 277, "top": 353, "height": 16, "left": 81}, "words": "本品辅料为:醋酸钠、氯化钠、冰醋酸和注射用水"}, {"probability": {"variance": 0.000672, "average": 0.988206, "min": 0.886093}, "location": {"width": 234, "top": 369, "height": 16, "left": 85}, "words": "【性状】本品为无色或几乎无色的澄明液体"}, {"probability": {"variance": 0.000733, "average": 0.992685, "min": 0.840829}, "location": {"width": 419, "top": 384, "height": 16, "left": 86}, "words": "【适应症】预防和治疗癌症化疗引起的恶心和呕吐。治疗手术后的恶心和呕吐"}, {"probability": {"variance": 0.000624, "average": 0.979338, "min": 0.906782}, "location": {"width": 177, "top": 401, "height": 15, "left": 86}, "words": "【规格】按C1H2N2O2计(1)2"}, {"probability": {"variance": 0.003043, "average": 0.961309, "min": 0.866499}, "location": {"width": 30, "top": 402, "height": 10, "left": 328}, "words": "2)5m"}, {"probability": {"variance": 0.000952, "average": 0.98844, "min": 0.848854}, "location": {"width": 538, "top": 415, "height": 17, "left": 86}, "words": "【用法用量】1.预防和治疗癌症化疗引起的恶心和呕吐:在任何化疗周期中,本品最多可应用6天"}, {"probability": {"variance": 0.001216, "average": 0.986659, "min": 0.771877}, "location": {"width": 552, "top": 430, "height": 18, "left": 90}, "words": "(1)成人:推荐剂量为5mg/天。推荐第一天采用静脉途径给药,以后改为口服给药每天一次最多5"}, {"probability": {"variance": 0.002436, "average": 0.981109, "min": 0.666281}, "location": {"width": 572, "top": 447, "height": 16, "left": 56}, "words": "天。参照以下方法给药:第1天静脉给药:将本品5mg(1安瓿)溶于100毫升常用输注液中(生理盐水"}, {"probability": {"variance": 0.00126, "average": 0.987634, "min": 0.782984}, "location": {"width": 546, "top": 463, "height": 16, "left": 57}, "words": "林格氏液或5%葡萄糖溶液)在化疗前快速静脉滴注(15分钟以上);或缓慢静脉推注(速度为2mg"}, {"probability": {"variance": 0.010404, "average": 0.960126, "min": 0.518714}, "location": {"width": 582, "top": 479, "height": 15, "left": 58}, "words": "5mg/5m1的安约3分钟注射完》:或缓慢加入已有的静脉输液中。第26天口服给药每天一次口服"}, {"probability": {"variance": 0.006135, "average": 0.97427, "min": 0.501804}, "location": {"width": 584, "top": 494, "height": 17, "left": 57}, "words": "给药5g,于早晨起床时(至少于早餐前一小时)用水送服。(2)元童一般不推荐用儿童,如病情需要"}, {"probability": {"variance": 0.001217, "average": 0.986664, "min": 0.815623}, "location": {"width": 346, "top": 512, "height": 15, "left": 57}, "words": "必须使用时,可参照如下方法给药:2岁以上的儿童推荐剂量0"}, {"probability": {"variance": 0.004287, "average": 0.966234, "min": 0.762911}, "location": {"width": 177, "top": 507, "height": 18, "left": 464}, "words": "最高可达5mg/天。第1天静脉"}, {"probability": {"variance": 0.004887, "average": 0.973445, "min": 0.678191}, "location": {"width": 583, "top": 526, "height": 17, "left": 57}, "words": "给药:将本品5mg溶于100ml常用输注液中(生理盐水、林格氏液或5%葡萄糖溶液)于化疗前快速静脉演"}, {"probability": {"variance": 0.004181, "average": 0.978843, "min": 0.670636}, "location": {"width": 585, "top": 542, "height": 18, "left": 56}, "words": "注15分钟以上或缓慢静脉推注或缓慢加入已有的静脉输液中。第2~6天可改为口服给药:从安瓿中取适"}, {"probability": {"variance": 0.001079, "average": 0.989116, "min": 0.835845}, "location": {"width": 552, "top": 558, "height": 18, "left": 57}, "words": "量的盐酸托烷司琼注射液,用桔子汁或可乐稀释后,在早晨起床时(至少于早餐前1小时)迅速服下"}, {"probability": {"variance": 0.001219, "average": 0.984985, "min": 0.819467}, "location": {"width": 561, "top": 573, "height": 17, "left": 80}, "words": "2.治疗手术后的恶心呕吐:成人推荐剂量为2mg,溶于生理盐水、林格氏液或5%葡萄糖溶液内静脉输"}, {"probability": {"variance": 0.00616, "average": 0.978545, "min": 0.570366}, "location": {"width": 355, "top": 590, "height": 16, "left": 57}, "words": "注或缓慢静脉注射(30秒以上)。目前没有儿童术后应用的经验"}, {"probability": {"variance": 0.00384, "average": 0.974211, "min": 0.635472}, "location": {"width": 559, "top": 605, "height": 16, "left": 81}, "words": "3.司巴丁/多聚异喹胍慢代谢者的应用:尽管慢代谢者消除相半衰期比正常代谢者长4-5倍,但应用"}, {"probability": {"variance": 0.005404, "average": 0.975182, "min": 0.561997}, "location": {"width": 571, "top": 622, "height": 15, "left": 57}, "words": "推荐剂量的托烷司琼没有药物引起毒性反应的报道。因此,在为期6天的应用中,慢代谢者无需减低剂量"}, {"probability": {"variance": 0.003325, "average": 0.974399, "min": 0.73954}, "location": {"width": 284, "top": 638, "height": 16, "left": 57}, "words": "这些患者中最常见头痛和便秘的报道《见不良反应"}, {"probability": {"variance": 0.000705, "average": 0.987906, "min": 0.851338}, "location": {"width": 560, "top": 651, "height": 20, "left": 82}, "words": "4.肝或肾功能不全患者的应用:肝硬化或肾功能不全患者的血浆药物浓度则较正常代谢的健康志愿"}, {"probability": {"variance": 0.001715, "average": 0.978808, "min": 0.809436}, "location": {"width": 584, "top": 668, "height": 18, "left": 57}, "words": "者高约50%,但在急性肝炎或脂肪肝患者中,盐酸托烷司琼的药代动力学无改变。仅在静脉应用时需减量"}, {"probability": {"variance": 0.005007, "average": 0.965274, "min": 0.647825}, "location": {"width": 552, "top": 699, "height": 16, "left": 87}, "words": "【不良反应】临床研究中最常报道的不良反应为应用2mg引起的头痛(22%及应用5mg引起的便秘(11%)"}, {"probability": {"variance": 0.010075, "average": 0.956945, "min": 0.523326}, "location": {"width": 582, "top": 714, "height": 19, "left": 58}, "words": "健康志愿者中,这些不良反应在慢代谢者中比正常代谢者更为常见(见司巴丁/多架异喹胍慢代谢者的应用)"}, {"probability": {"variance": 0.016359, "average": 0.944908, "min": 0.50899}, "location": {"width": 547, "top": 730, "height": 18, "left": 82}, "words": "偶尔也有头晕、疲乏、胃肠功能素乱如腹痛和腹泻的报道(0:1-5%)。与其它5-HT3受体拮抗剂相似"}, {"probability": {"variance": 0.000425, "average": 0.98754, "min": 0.913311}, "location": {"width": 583, "top": 745, "height": 19, "left": 58}, "words": "也有虚脱、晕厥和心跳停止的个案报道:但这些事件与托烷司琼的使用没有确切的因果关系,这些反应可"}, {"probability": {"variance": 0.003388, "average": 0.983067, "min": 0.750994}, "location": {"width": 213, "top": 764, "height": 14, "left": 58}, "words": "能会由细胞毒性药物或原有的疾病引起"}, {"probability": {"variance": 0.002268, "average": 0.980173, "min": 0.791294}, "location": {"width": 559, "top": 777, "height": 16, "left": 83}, "words": "与其它5-HT3受体拮抗剂相似,也有以下一种或多种I型变态反应发生的个案报道:面部潮红和/或"}, {"probability": {"variance": 0.008509, "average": 0.967926, "min": 0.565106}, "location": {"width": 339, "top": 794, "height": 15, "left": 58}, "words": "全身风疹、胸部压迫感、呼吸困难、急性支气管痉李和低血压"}, {"probability": {"variance": 0.002858, "average": 0.984949, "min": 0.65772}, "location": {"width": 558, "top": 809, "height": 16, "left": 83}, "words": "在上市后应用期间,报告了非常罕见的过敏反应:皮疹、红斑、过敏性休克。由于产生这些报告的患"}, {"probability": {"variance": 0.002279, "average": 0.985423, "min": 0.693986}, "location": {"width": 563, "top": 825, "height": 18, "left": 58}, "words": "者人数未明确,且可能存在混淆因素,因此不能准确估算药物不良反应发生率或确定与药物的因果关系"}, {"probability": {"variance": 0.003417, "average": 0.970593, "min": 0.71455}, "location": {"width": 555, "top": 841, "height": 16, "left": 86}, "words": "【禁忌】孕妇禁用。对托烷司琼过敏或其他5-HT3受体拮抗剂(如恩丹西酮、格拉司琼)或任何一种"}, {"probability": {"variance": 9e-06, "average": 0.997545, "min": 0.990673}, "location": {"width": 125, "top": 859, "height": 14, "left": 59}, "words": "赋形剂过敏的患者禁用"}, {"probability": {"variance": 0.001113, "average": 0.989613, "min": 0.783415}, "location": {"width": 554, "top": 873, "height": 16, "left": 87}, "words": "【注意事项】1、高血压未控制的患者,用药后可能引起血压进一步升高,故高血压的患者应慎用,其"}, {"probability": {"variance": 0.000743, "average": 0.987952, "min": 0.863997}, "location": {"width": 583, "top": 889, "height": 16, "left": 58}, "words": "用量不宜超过10毫克/天。2、盐酸托烷司琼常见的不良反应是头晕和疲劳,患者服药后在驾车或操纵机"}, {"probability": {"variance": 0.006193, "average": 0.976411, "min": 0.504299}, "location": {"width": 583, "top": 904, "height": 17, "left": 58}, "words": "械者应慎用。3、肝肾功能障碍者使用本品半衰期延长,但这种变化在每天5mg,连续用药6天的治疗中不"}], "language": 3}